Global Alzheimer’s Disease Diagnostics Market
The Alzheimer's Disease Diagnostics Market is projected to reach USD 7.15 billion by 2033. In 2023, the market size was USD 4.14 billion, and it is anticipated to grow at a compound annual growth rate (CAGR) of 8.90% from 2023 to 2033. Diagnosing Alzheimer's disease involves a thorough evaluation of an individual's cognitive abilities, memory, behavior, and functional skills to identify the presence and progression of the condition. Diagnostic tools include cognitive tests, brain imaging (such as MRI or PET scans), medical history assessments, and evaluations of daily living activities. These tools help clinicians distinguish Alzheimer's disease from other types of dementia and detect characteristic brain changes like amyloid plaques and tau tangles. Early and accurate diagnosis is essential for initiating proper interventions and providing support to individuals and their families coping with this neurodegenerative disorder.
The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.
Segments covered
The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.
Segments covered
- By Type (Nervous System, Examination, Genetic Testing, Minor Mental State Examination, Brain Imaging)
- By Diagnostic Test (Genetic Testing, Positron Emission Tomography, Electroencephalography, Magnetic Resonance Imaging, Computed Tomography, Neurological Exam, Mini-mental State Exam (MMSE), Brain Imaging, Others)
- By End User (Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, Academic Research Center)
- Hoffmann-La Roche
- Bristol-Myers Squibb
- AstraZeneca PLC
- Corium Inc
- Eisai Co. Ltd
- Biogen Inc
- Johnson & Johnson
- Eli Lilly and Company
- Lupin Limited
- AbbVie Inc
CHAPTER 1. EXECUTIVE SUMMARY
CHAPTER 2. SCOPE OF THE STUDY
2.1. Market Definition
2.2. Market Scope & Segmentation
2.2.1. Objective of Report
CHAPTER 3. EVOLVE BI METHODOLOGY
3.1. Data Collection & Validation Approach
3.2. Market Size Estimation and Forecast
CHAPTER 4. EXCLUSIVE ANALYSIS
4.1. Market Opportunity Score
4.1.1. Type Segement – Market Opportunity Score
4.1.2. Diagnostic Test Segment – Market Opportunity Score
4.1.3. End User Segment – Market Opportunity Score
4.2. Key Market Influencing Indicators
CHAPTER 5. MARKET INSIGHTS AND TRENDS
5.1. Value Chain Analysis
5.1.1. Raw Material
5.1.2. Manufacturing Process
5.1.3. Distribution Channel
5.1.4. End User
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Buyers
5.2.2. Bargaining Power of Suppliers
5.2.3. Threat of New Entrant
5.2.4. Threat of Substitute
5.2.5. Industry Rivalry
5.3. COVID-19 Impact and Post COVID Scenario on Alzheimers Disease Diagnostics Market
5.3.1. Impact of COVID-19
5.3.2. Government Support and Industry Revival Policies
5.3.3. Measures Taken by Companies to Mitigate Negative Impact
5.3.4. Post COVID Trend
CHAPTER 6. MARKET DYNAMICS
6.1. Introduction
6.2. Drivers
6.2.1. Driver 1
6.2.2. Driver 2
6.2.3. Driver 3
6.3. Restraints
6.3.1. Restraint 1
6.3.2. Restraint 2
6.4. Opportunity
6.4.1. Opportunity 1
CHAPTER 7. GLOBAL ALZHEIMERS DISEASE DIAGNOSTICS MARKET, BY TYPE
7.1. Introduction
7.1.1. Nervous System
7.1.2. Examination
7.1.3. Genetic Testing
7.1.4. Minor Mental State Examination
7.1.5. Brain Imaging
CHAPTER 8. GLOBAL ALZHEIMERS DISEASE DIAGNOSTICS MARKET, BY DIAGNOSTIC TEST
8.1. Introduction
8.1.1. Genetic Testing
8.1.2. Positron Emission Tomography
8.1.3. Electroencephalography
8.1.4. Magnetic Resonance Imaging
8.1.5. Computed Tomography
8.1.6. Neurological Exam
8.1.7. Mini-mental State Exam (MMSE)
8.1.8. Brain Imaging
8.1.9. Others
CHAPTER 9. GLOBAL ALZHEIMERS DISEASE DIAGNOSTICS MARKET, BY END USER
9.1. Introduction
9.1.1. Clinics
9.1.2. Hospitals
9.1.3. Diagnostic Centers
9.1.4. Pharmaceutical Companies
9.1.5. Academic Research Center
CHAPTER 10. GLOBAL ALZHEIMERS DISEASE DIAGNOSTICS MARKET, BY REGION
10.1. Introduction
10.2. NORTH AMERICA
10.2.1. North America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.2.2. North America: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.2.3. North America: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.2.4. North America: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.2.5. US
10.2.5.1. US: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.2.5.2. US: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.2.5.3. US: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.2.6. CANADA
10.2.6.1. Canada: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.2.6.2. Canada: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.2.6.3. Canada: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.2.7. MEXICO
10.2.7.1. Mexico: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.2.7.2. Mexico: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.2.7.3. Mexico: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3. Europe
10.3.1. Europe: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.3.2. Europe: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.3. Europe: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.4. Europe: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.5. U.K.
10.3.5.1. U.K.: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.5.2. U.K.: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.5.3. U.K.: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.6. GERMANY
10.3.6.1. Germany: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.6.2. Germany: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.6.3. Germany: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.7. FRANCE
10.3.7.1. France: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.7.2. France: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.7.3. France: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.8. ITALY
10.3.8.1. Italy: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.8.2. Italy: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.8.3. Italy: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.9. SPAIN
10.3.9.1. Spain: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.9.2. Spain: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.9.3. Spain: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.10. BENELUX
10.3.10.1. BeNeLux: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.10.2. BeNeLux: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.10.3. BeNeLux: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.11. RUSSIA
10.3.11.1. Russia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.11.2. Russia: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.11.3. Russia: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.12. REST OF EUROPE
10.3.12.1. Rest of Europe: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.12.2. Rest of Europe: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.12.3. Rest of Europe: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4. Asia Pacific
10.4.1. Asia Pacific: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.4.2. Asia Pacific: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.3. Asia Pacific: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.4. Asia Pacific: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.5. CHINA
10.4.5.1. China: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.5.2. China: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.5.3. China: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.6. JAPAN
10.4.6.1. Japan: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.6.2. Japan: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.6.3. Japan: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.7. INDIA
10.4.7.1. India: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.7.2. India: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.7.3. India: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.8. SOUTH KOREA
10.4.8.1. South Korea: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.8.2. South Korea: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.8.3. South Korea: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.9. THAILAND
10.4.9.1. Thailand: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.9.2. Thailand: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.9.3. Thailand: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.10. INDONESIA
10.4.10.1. Indonesia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.10.2. Indonesia: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.10.3. Indonesia: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.11. MALAYSIA
10.4.11.1. Malaysia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.11.2. Malaysia: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.11.3. Malaysia: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.12. AUSTRALIA
10.4.12.1. Australia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.12.2. Australia: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.12.3. Australia: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.13. REST FO ASIA PACIFIC
10.4.13.1. Rest fo Asia Pacific: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.13.2. Rest fo Asia Pacific: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.13.3. Rest fo Asia Pacific: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.5. South America
10.5.1. South America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.5.2. South America: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.5.3. South America: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.5.4. South America: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.5.5. BRAZIL
10.5.5.1. Brazil: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.5.5.2. Brazil: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.5.5.3. Brazil: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.5.6. ARGENTINA
10.5.6.1. Argentina: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.5.6.2. Argentina: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.5.6.3. Argentina: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.5.7. REST OF SOUTH AMERICA
10.5.7.1. Rest of South America: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.5.7.2. Rest of South America: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.5.7.3. Rest of South America: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.6. Middle East & Africa
10.6.1. Middle East & Africa: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.6.2. Middle East & Africa: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.6.3. Middle East & Africa: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.6.4. Middle East & Africa: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.6.5. SAUDI ARABIA
10.6.5.1. Saudi Arabia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.6.5.2. Saudi Arabia: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.6.5.3. Saudi Arabia: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.6.6. UAE
10.6.6.1. UAE: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.6.6.2. UAE: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.6.6.3. UAE: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.6.7. EGYPT
10.6.7.1. Egypt: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.6.7.2. Egypt: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.6.7.3. Egypt: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.6.8. SOUTH AFRICA
10.6.8.1. South Africa: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.6.8.2. South Africa: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.6.8.3. South Africa: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.6.9. REST OF MIDDLE EAST & AFRICA
10.6.9.1. Rest of Middle East & Africa: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.6.9.2. Rest of Middle East & Africa: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.6.9.3. Rest of Middle East & Africa: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
CHAPTER 12. COMPETITIVE LANDSCAPE
12.1. Competitior Benchmarking 2023
12.2. Market Share Analysis
12.3. Key Developments Analysis By Top 5 Companies
12.4. Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players
CHAPTER 13. COMPANY PROFILES
13.1. F. Hoffmann-La Roche
13.1.1. Business Overview
13.1.2. Financial Analysis
13.1.2.1. Business Segment Revenue, 2020, 2021, 2022, $ Million
13.1.2.2. Geographic Revenue Mix, 2022 (% Share)
13.1.3. Product Portfolio
13.1.4. Recent Development and Strategies Adopted
13.1.5. SWOT Analysis
13.2. Bristol-Myers Squibb
13.3. AstraZeneca PLC
13.4. Corium Inc
13.5. Eisai Co. Ltd
13.6. Biogen Inc
13.7. Johnson & Johnson
13.8. Eli Lilly and Company
13.9. Lupin Limited
13.10. AbbVie Inc
CHAPTER 2. SCOPE OF THE STUDY
2.1. Market Definition
2.2. Market Scope & Segmentation
2.2.1. Objective of Report
CHAPTER 3. EVOLVE BI METHODOLOGY
3.1. Data Collection & Validation Approach
3.2. Market Size Estimation and Forecast
CHAPTER 4. EXCLUSIVE ANALYSIS
4.1. Market Opportunity Score
4.1.1. Type Segement – Market Opportunity Score
4.1.2. Diagnostic Test Segment – Market Opportunity Score
4.1.3. End User Segment – Market Opportunity Score
4.2. Key Market Influencing Indicators
CHAPTER 5. MARKET INSIGHTS AND TRENDS
5.1. Value Chain Analysis
5.1.1. Raw Material
5.1.2. Manufacturing Process
5.1.3. Distribution Channel
5.1.4. End User
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Buyers
5.2.2. Bargaining Power of Suppliers
5.2.3. Threat of New Entrant
5.2.4. Threat of Substitute
5.2.5. Industry Rivalry
5.3. COVID-19 Impact and Post COVID Scenario on Alzheimers Disease Diagnostics Market
5.3.1. Impact of COVID-19
5.3.2. Government Support and Industry Revival Policies
5.3.3. Measures Taken by Companies to Mitigate Negative Impact
5.3.4. Post COVID Trend
CHAPTER 6. MARKET DYNAMICS
6.1. Introduction
6.2. Drivers
6.2.1. Driver 1
6.2.2. Driver 2
6.2.3. Driver 3
6.3. Restraints
6.3.1. Restraint 1
6.3.2. Restraint 2
6.4. Opportunity
6.4.1. Opportunity 1
CHAPTER 7. GLOBAL ALZHEIMERS DISEASE DIAGNOSTICS MARKET, BY TYPE
7.1. Introduction
7.1.1. Nervous System
7.1.2. Examination
7.1.3. Genetic Testing
7.1.4. Minor Mental State Examination
7.1.5. Brain Imaging
CHAPTER 8. GLOBAL ALZHEIMERS DISEASE DIAGNOSTICS MARKET, BY DIAGNOSTIC TEST
8.1. Introduction
8.1.1. Genetic Testing
8.1.2. Positron Emission Tomography
8.1.3. Electroencephalography
8.1.4. Magnetic Resonance Imaging
8.1.5. Computed Tomography
8.1.6. Neurological Exam
8.1.7. Mini-mental State Exam (MMSE)
8.1.8. Brain Imaging
8.1.9. Others
CHAPTER 9. GLOBAL ALZHEIMERS DISEASE DIAGNOSTICS MARKET, BY END USER
9.1. Introduction
9.1.1. Clinics
9.1.2. Hospitals
9.1.3. Diagnostic Centers
9.1.4. Pharmaceutical Companies
9.1.5. Academic Research Center
CHAPTER 10. GLOBAL ALZHEIMERS DISEASE DIAGNOSTICS MARKET, BY REGION
10.1. Introduction
10.2. NORTH AMERICA
10.2.1. North America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.2.2. North America: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.2.3. North America: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.2.4. North America: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.2.5. US
10.2.5.1. US: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.2.5.2. US: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.2.5.3. US: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.2.6. CANADA
10.2.6.1. Canada: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.2.6.2. Canada: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.2.6.3. Canada: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.2.7. MEXICO
10.2.7.1. Mexico: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.2.7.2. Mexico: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.2.7.3. Mexico: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3. Europe
10.3.1. Europe: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.3.2. Europe: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.3. Europe: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.4. Europe: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.5. U.K.
10.3.5.1. U.K.: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.5.2. U.K.: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.5.3. U.K.: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.6. GERMANY
10.3.6.1. Germany: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.6.2. Germany: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.6.3. Germany: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.7. FRANCE
10.3.7.1. France: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.7.2. France: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.7.3. France: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.8. ITALY
10.3.8.1. Italy: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.8.2. Italy: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.8.3. Italy: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.9. SPAIN
10.3.9.1. Spain: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.9.2. Spain: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.9.3. Spain: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.10. BENELUX
10.3.10.1. BeNeLux: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.10.2. BeNeLux: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.10.3. BeNeLux: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.11. RUSSIA
10.3.11.1. Russia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.11.2. Russia: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.11.3. Russia: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.3.12. REST OF EUROPE
10.3.12.1. Rest of Europe: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.3.12.2. Rest of Europe: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.3.12.3. Rest of Europe: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4. Asia Pacific
10.4.1. Asia Pacific: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.4.2. Asia Pacific: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.3. Asia Pacific: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.4. Asia Pacific: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.5. CHINA
10.4.5.1. China: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.5.2. China: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.5.3. China: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.6. JAPAN
10.4.6.1. Japan: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.6.2. Japan: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.6.3. Japan: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.7. INDIA
10.4.7.1. India: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.7.2. India: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.7.3. India: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.8. SOUTH KOREA
10.4.8.1. South Korea: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.8.2. South Korea: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.8.3. South Korea: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.9. THAILAND
10.4.9.1. Thailand: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.9.2. Thailand: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.9.3. Thailand: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.10. INDONESIA
10.4.10.1. Indonesia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.10.2. Indonesia: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.10.3. Indonesia: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.11. MALAYSIA
10.4.11.1. Malaysia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.11.2. Malaysia: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.11.3. Malaysia: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.12. AUSTRALIA
10.4.12.1. Australia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.12.2. Australia: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.12.3. Australia: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.4.13. REST FO ASIA PACIFIC
10.4.13.1. Rest fo Asia Pacific: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.4.13.2. Rest fo Asia Pacific: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.4.13.3. Rest fo Asia Pacific: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.5. South America
10.5.1. South America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.5.2. South America: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.5.3. South America: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.5.4. South America: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.5.5. BRAZIL
10.5.5.1. Brazil: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.5.5.2. Brazil: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.5.5.3. Brazil: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.5.6. ARGENTINA
10.5.6.1. Argentina: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.5.6.2. Argentina: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.5.6.3. Argentina: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.5.7. REST OF SOUTH AMERICA
10.5.7.1. Rest of South America: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.5.7.2. Rest of South America: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.5.7.3. Rest of South America: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.6. Middle East & Africa
10.6.1. Middle East & Africa: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.6.2. Middle East & Africa: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.6.3. Middle East & Africa: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.6.4. Middle East & Africa: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.6.5. SAUDI ARABIA
10.6.5.1. Saudi Arabia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.6.5.2. Saudi Arabia: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.6.5.3. Saudi Arabia: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.6.6. UAE
10.6.6.1. UAE: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.6.6.2. UAE: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.6.6.3. UAE: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.6.7. EGYPT
10.6.7.1. Egypt: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.6.7.2. Egypt: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.6.7.3. Egypt: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.6.8. SOUTH AFRICA
10.6.8.1. South Africa: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.6.8.2. South Africa: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.6.8.3. South Africa: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
10.6.9. REST OF MIDDLE EAST & AFRICA
10.6.9.1. Rest of Middle East & Africa: Market Size and Forecast, By Type, 2023 – 2033 ($ Million)
10.6.9.2. Rest of Middle East & Africa: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million)
10.6.9.3. Rest of Middle East & Africa: Market Size and Forecast, By End User, 2023 – 2033 ($ Million)
CHAPTER 12. COMPETITIVE LANDSCAPE
12.1. Competitior Benchmarking 2023
12.2. Market Share Analysis
12.3. Key Developments Analysis By Top 5 Companies
12.4. Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players
CHAPTER 13. COMPANY PROFILES
13.1. F. Hoffmann-La Roche
13.1.1. Business Overview
13.1.2. Financial Analysis
13.1.2.1. Business Segment Revenue, 2020, 2021, 2022, $ Million
13.1.2.2. Geographic Revenue Mix, 2022 (% Share)
13.1.3. Product Portfolio
13.1.4. Recent Development and Strategies Adopted
13.1.5. SWOT Analysis
13.2. Bristol-Myers Squibb
13.3. AstraZeneca PLC
13.4. Corium Inc
13.5. Eisai Co. Ltd
13.6. Biogen Inc
13.7. Johnson & Johnson
13.8. Eli Lilly and Company
13.9. Lupin Limited
13.10. AbbVie Inc
